» Articles » PMID: 12601481

[Interlaboratory Trial 2000 " Immunohistochemistry" of the German Society for Pathology and the Professional Association of German Pathologists]

Overview
Journal Pathologe
Specialty Pathology
Date 2003 Feb 26
PMID 12601481
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Early in 2000 an interlaboratory trial on immunohistochemistry was held in Germany in which 172 pathologists took part. Each pathologist received one H&E stained and five unstained slides of five different tumors to reach a diagnosis based on immunohistochemical stains. Additionally, the diagnosis-independent staining quality was assessed by using a multi-tissue block. Altogether, 828 diagnoses were made, among which 57% (468) were correct. The individual steps of immunohistochemistry (tentative morphological diagnosis, choice of primary antibodies, technical staining quality, conclusions from the diagnosis and rendering a final diagnosis) were assessed independently. Although each of these steps was correlated to the correct final diagnosis, in the multivariate analysis only the tentative diagnosis, choice of primary antibodies and the conclusions drawn from individual stains were independent factors to reach the correct final diagnosis. In the diagnostic part of the interlaboratory trial, the technical quality of the immunostaining was not an independent variable to reach a correct diagnosis. In contrast, the results of the multi-tissue block proved that the immunohistochemical staining quality has to be standardized to reach reproducible results in defining the estrogen receptor expression as a basis for therapeutic decisions.

Citing Articles

[Determination of tumor biological parameters in breast cancer: round robin testing for quality assurance].

Liessem S, Winkens W, Jonigk D, Wasielewski R, Fisseler-Eckhoff A, Ruschoff J Pathologe. 2014; 35(1):61-71.

PMID: 24496992 DOI: 10.1007/s00292-013-1837-3.


Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany.

von Wasielewski R, Krusche C, Ruschoff J, Fisseler-Eckhoff A, Kreipe H Breast Care (Basel). 2011; 3(2):128-133.

PMID: 21373217 PMC: 2931088. DOI: 10.1159/000121885.


Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer.

Breast Care (Basel). 2010; 5(3):185-187.

PMID: 21049068 PMC: 2931060. DOI: 10.1159/000315039.


[Interlaboratory trials for quality assurance of breast cancer biomarkers in Germany].

Krusche C, von Wasielewski R, Ruschoff J, Fisseler-Eckhoff A, Kreipe H Pathologe. 2008; 29(4):315-20.

PMID: 18504581 DOI: 10.1007/s00292-008-1004-4.